The "2017 International Summit Forum on Translational Neurology" was held successfully during July 21-23 in Zhengzhou, Henan Province, China. Basic researchers and clinical experts both from China and abroad were invited to attend, along with representatives of research institutions and businesses, while Neuroimmunology and Neuroinflammation (NN) editorial team members in attendance included Rui-Rui Zhang and A-Ni Yuan. There was a presentation about the aims of the conference, namely to provide a forum for those working in the field of clinical neurology, facilitate continuing education and training for clinicians, foster exchange of information about new technologies for clinical diagnosis and treatment, and promote clinical translation of medical research through these in-depth academic exchanges.
On July 22, our team members listened carefully to lectures by experts from all over the world, and learnt about the dynamic state of and latest achievements in research into cerebral ischemia, cerebral hemorrhage, neurological rehabilitation, neurodegenerative disease, nerve involvement, and transformation of treatments for vertigo. Our team also spent time on discussion with the experts after the meeting.
Our team was honored to listen to a lecture entitled: “Bench to bedside translational medicine: steps” by the Honorary Conference President, President (2014-2016) of the International Society for Neuroimmunology, Academician of Canada’s Royal Academy of Sciences, and the Canada Research Chair in Neuroimmunology, Professor V. Wee Yong. The managing editor of NN journal, Rui-Rui Zhang, introduced basic information about the journal including our policies on open access, peer review, Editorial Board members, published articles, and database indexing, etc. After careful consideration, Prof. Yong accepted our sincere invitation, in the name of our Editor-in-Chief, Professor Gang Zhao, and was willing to join us as Honorary Editor-in-Chief.
Meanwhile, Prof. Yong also recommended Professor Meng-Zhou Xue, a doctoral supervisor at the Second Affiliated Hospital of Zhengzhou University and Adjunct Professor at the University of Calgary, to our journal as an Editorial Board member who could make valuable contributions to NN.
We firmly believe that NN journal will have bright prospects thanks to the joint efforts of Prof. Yong, Prof. Xue, all of the Editorial Board members, and the editorial staff. While expressing gratitude to our experts for their support and reliability, our journal team will make every effort to provide better service to experts in the field, strive for efficient and rapid performance, and endeavor to make NN an influential international high-quality journal which provides a broad and convenient platform for academic exchange among global experts in the fields of neuroimmunology and neuroinflammation.
V. Wee Yong is a Professor in the Department of Clinical Neuroscience at the University of Calgary and the Canada Research Chair in Neuroimmunology. Prof. Yong’s research interests are focused on neuroimmunology (multiple sclerosis, spinal cord injury, and malignant glioma), neuroprotection, and central nervous system regeneration. Professor Yong has published 280 SCI articles in Nature Reviews Neurology, Brain, Nature Neuroscience, Nature Reviews Neuroscience, and Journal of Neuroscience. In other journals, they have been cited more than 27,000 times.
Meng-Zhou Xue is a Doctor at the University of Manitoba, Canada, and a Postdoctoral Research Fellow and Adjunct professor at The University of Calgary. Dr. Xue is also a doctoral supervisor for The Second Affiliated Hospital of Zhengzhou University, The Yellow River scholar of Henan University, and Director of the physicians and professors in the Department of Neurology of the First Affiliated Hospital of Henan University. Professor Xue was awarded the first prize for medical science and technology progress, and the third prize for scientific and technological achievement, in Henan Province. He has published more than 40 papers, including 30 SCI papers, which have been cited more than 1,800 times.